Cancer Causes & Control

, Volume 23, Issue 6, pp 967–981 | Cite as

Diabetes and cancer I: risk, survival, and implications for screening

  • Adedayo A. OnitiloEmail author
  • Jessica M. Engel
  • Ingrid Glurich
  • Rachel V. Stankowski
  • Gail M. Williams
  • Suhail A. Doi
Original paper


Type 2 diabetes mellitus (DM) and cancer are common diseases that are frequently diagnosed in the same individual. An association between the two conditions has long been postulated. Here, we review the epidemiological evidence for increased risk of cancer, decreased cancer survival, and decreased rates of cancer screening in diabetic patients. The risk for several cancers, including cancers of the pancreas, liver, colorectum, breast, urinary tract, and endometrium, is increased in patients with DM. In a pooled risk analysis weighting published meta-analytic relative risk (RR) for individual cancer by differences in their incidence rates, we found a population RR of 0.97 (95 % CI, 0.75–1.25) in men and 1.29 (95 % CI, 1.16–1.44) in women. All meta-analyses showed an increased relative risk for cancer in diabetic men, except studies of prostate cancer, in which a protective effect was observed. The relationship between diabetes and cancer appears to be complex, and at present, a clear temporal relationship between the two conditions cannot be defined. DM also impacts negatively on cancer-related survival outcomes and cancer screening rates. The overwhelming evidence for lower cancer screening rates, increased incidence of certain cancers, and poorer prognosis after cancer diagnosis in diabetic patients dictates a need for improved cancer care in diabetic individuals through improved screening measures, development of risk assessment tools, and consideration of cancer prevention strategies in diabetic patients. Part two of this review focuses on the biological and pharmacological mechanisms that may account for the association between DM and cancer.


Diabetes Cancer Review Meta-analysis 


  1. 1.
    Chowdhury TA (2010) Diabetes and cancer. QJM 103(12):905–915PubMedCrossRefGoogle Scholar
  2. 2.
    Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103–1123PubMedCrossRefGoogle Scholar
  3. 3.
    Adami HO, McLaughlin J, Ekbom A et al (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2(5):307–314PubMedCrossRefGoogle Scholar
  4. 4.
    Adami HO, Chow WH, Nyren O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88(20):1472–1477PubMedCrossRefGoogle Scholar
  5. 5.
    Alokail MS, Al-Daghri NM, Al-Attas OS, Hussain T (2009) Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women. Cardiovasc Diabetol 8:33PubMedCrossRefGoogle Scholar
  6. 6.
    Anderson KE, Anderson E, Mink PJ et al (2001) Diabetes and endometrial cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev 10(6):611–616PubMedGoogle Scholar
  7. 7.
    Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128(3):635–643PubMedCrossRefGoogle Scholar
  8. 8.
    Ben Q, Cai Q, Li Z et al (2011) The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer 47(2):248–254PubMedCrossRefGoogle Scholar
  9. 9.
    Bonelli L, Aste H, Bovo P et al (2003) Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas 27(2):143–149PubMedCrossRefGoogle Scholar
  10. 10.
    Campbell PT, Deka A, Jacobs EJ et al (2010) Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 139(4):1138–1146PubMedCrossRefGoogle Scholar
  11. 11.
    Cetin M, Colak R, Bayram F, Altinbas M, Unal A, Kelestimur F (2002) High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey. Diabetes Res Clin Pract 58(2):97–100PubMedCrossRefGoogle Scholar
  12. 12.
    Chao C, Page JH (2008) Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. Am J Epidemiol 168(5):471–480PubMedCrossRefGoogle Scholar
  13. 13.
    Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM (2005) Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129(2):504–511PubMedGoogle Scholar
  14. 14.
    Chari ST, Leibson CL, Rabe KG et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134(1):95–101PubMedCrossRefGoogle Scholar
  15. 15.
    Chen CQ, Fang LK, Cai SR et al (2010) Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J (Engl) 123(21):3084–3088Google Scholar
  16. 16.
    Chow WH, Gridley G, Nyren O et al (1995) Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 87(12):930–931PubMedCrossRefGoogle Scholar
  17. 17.
    DeMeo MT (2001) Pancreatic cancer and sugar diabetes. Nutr Rev 59(4):112–115PubMedGoogle Scholar
  18. 18.
    El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4(3):369–380PubMedCrossRefGoogle Scholar
  19. 19.
    Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273(20):1605–1609PubMedCrossRefGoogle Scholar
  20. 20.
    Fisher WE (2001) Diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease? World J Surg 25(4):503–508PubMedCrossRefGoogle Scholar
  21. 21.
    Flood A, Strayer L, Schairer C, Schatzkin A (2010) Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 21(8):1277–1284PubMedCrossRefGoogle Scholar
  22. 22.
    Friberg E, Orsini N, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50(7):1365–1374PubMedCrossRefGoogle Scholar
  23. 23.
    Friberg E, Mantzoros CS, Wolk A (2007) Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 16(2):276–280PubMedCrossRefGoogle Scholar
  24. 24.
    Frye JN, Inder WJ, Dobbs BR, Frizelle FA (2000) Pancreatic cancer and diabetes: is there a relationship? A case-controlled study. Aust N Z J Surg 70(10):722–724PubMedCrossRefGoogle Scholar
  25. 25.
    Fujino Y, Mizoue T, Tokui N, Yoshimura T (2001) Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev 17(5):374–379PubMedCrossRefGoogle Scholar
  26. 26.
    Gullo L, Pezzilli R, Morselli-Labate AM (1994) Diabetes and the risk of pancreatic cancer. N Engl J Med 331(2):81–84PubMedCrossRefGoogle Scholar
  27. 27.
    Gullo L, Pezzilli R (2004) Diabetes and pancreatic cancer. Pancreas 28(4):451–452PubMedCrossRefGoogle Scholar
  28. 28.
    Gupta S, Vittinghoff E, Bertenthal D et al (2006) New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 4(11):1366–1372PubMedCrossRefGoogle Scholar
  29. 29.
    Hassan MM, Curley SA, Li D et al (2010) Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 116(8):1938–1946PubMedCrossRefGoogle Scholar
  30. 30.
    He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA (2010) The association of diabetes with colorectal cancer risk: the multiethnic cohort. Br J Cancer 103(1):120–126PubMedCrossRefGoogle Scholar
  31. 31.
    Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15(6):548–555PubMedCrossRefGoogle Scholar
  32. 32.
    Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes–a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241(6):471–475PubMedCrossRefGoogle Scholar
  33. 33.
    Hu FB, Manson JE, Liu S et al (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91(6):542–547PubMedCrossRefGoogle Scholar
  34. 34.
    Huxley R, Ansary-Moghaddam A, de González AB, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083PubMedCrossRefGoogle Scholar
  35. 35.
    Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166(17):1871–1877PubMedCrossRefGoogle Scholar
  36. 36.
    Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ (2009) Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 15(42):5274–5278PubMedCrossRefGoogle Scholar
  37. 37.
    Khan M, Mori M, Fujino Y et al (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan collaborative cohort (JACC) study. Asian Pac J Cancer Prev 7(2):253–259PubMedGoogle Scholar
  38. 38.
    Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 13(6):915–919PubMedGoogle Scholar
  39. 39.
    Kuang TT, Jin dY, Wang DS et al (2009) Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China. J Dig Dis 10(1):26–29PubMedCrossRefGoogle Scholar
  40. 40.
    Kuriki K, Tokudome S, Tajima K (2004) Association between type II diabetes and colon cancer among Japanese with reference to changes in food intake. Asian Pac J Cancer Prev 5(1):28–35PubMedGoogle Scholar
  41. 41.
    Kuriki K, Hirose K, Tajima K (2007) Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 16(1):83–89PubMedCrossRefGoogle Scholar
  42. 42.
    La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953PubMedCrossRefGoogle Scholar
  43. 43.
    La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73(2):204–207PubMedCrossRefGoogle Scholar
  44. 44.
    Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97(22):1679–1687PubMedCrossRefGoogle Scholar
  45. 45.
    Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121(4):856–862PubMedCrossRefGoogle Scholar
  46. 46.
    Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST (2008) Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134(4):81–987CrossRefGoogle Scholar
  47. 47.
    Vinikoor LC, Long MD, Keku TO, Martin CF, Galanko JA, Sandler RS (2009) The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev 18(4):1239–1242PubMedCrossRefGoogle Scholar
  48. 48.
    Wang F, Gupta S, Holly EA (2006) Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. California. Cancer Epidemiol Biomarkers Prev 15(8):1458–1463CrossRefGoogle Scholar
  49. 49.
    Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147(9):816–825PubMedCrossRefGoogle Scholar
  50. 50.
    Yalniz M, Pour PM (2005) Diabetes mellitus: a risk factor for pancreatic cancer? Langenbecks Arch Surg 390(1):66–72PubMedCrossRefGoogle Scholar
  51. 51.
    La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 6(12):1007–1010PubMedGoogle Scholar
  52. 52.
    Larsson SC, Permert J, Hakansson N, Naslund I, Bergkvist L, Wolk A (2005) Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 93(11):1310–1315PubMedCrossRefGoogle Scholar
  53. 53.
    Larsson SC, Orsini N, Brismar K, Wolk A (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49(12):2819–2823PubMedCrossRefGoogle Scholar
  54. 54.
    Li CI, Daling JR, Tang MT, Malone KE (2011) Relationship between diabetes and risk of second primary contralateral breast cancer. Breast Cancer Res Treat 125(2):545–551PubMedCrossRefGoogle Scholar
  55. 55.
    Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT (2011) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control 22(2):189–197PubMedCrossRefGoogle Scholar
  56. 56.
    Limburg PJ, Anderson KE, Johnson TW et al (2005) Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev 14(1):133–137PubMedGoogle Scholar
  57. 57.
    Limburg PJ, Vierkant RA, Fredericksen ZS et al (2006) Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 101(8):1872–1879PubMedCrossRefGoogle Scholar
  58. 58.
    Lindblad P, Chow WH, Chan J et al (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42(1):107–112PubMedCrossRefGoogle Scholar
  59. 59.
    Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2008) Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 98(9):1582–1585PubMedCrossRefGoogle Scholar
  60. 60.
    Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98(3):349–356PubMedCrossRefGoogle Scholar
  61. 61.
    Luo J, Iwasaki M, Inoue M et al (2007) Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan–the JPHC study. Cancer Causes Control 18(6):603–612PubMedCrossRefGoogle Scholar
  62. 62.
    Mackenzie T, Zens MS, Ferrara A, Schned A, Karagas MR (2011) Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer 117(7):1552–1556PubMedCrossRefGoogle Scholar
  63. 63.
    Mitri J, Castillo J, Pittas AG (2008) Diabetes and risk of Non-Hodgkin’s lymphoma: a meta-analysis of observational studies. Diabetes Care 31(12):2391–2397PubMedCrossRefGoogle Scholar
  64. 64.
    Ng Y, Husain I, Waterfall N (2003) Diabetes mellitus and bladder cancer–an epidemiological relationship? Pathol Oncol Res 9(1):30–31PubMedCrossRefGoogle Scholar
  65. 65.
    Noto H, Osame K, Sasazuki T, Noda M (2010) Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications 24(5):345–353PubMedCrossRefGoogle Scholar
  66. 66.
    Ogunleye AA, Ogston SA, Morris AD, Evans JM (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101(7):1199–1201PubMedCrossRefGoogle Scholar
  67. 67.
    Parazzini F, La Vecchia C, Negri E et al (1999) Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer 81(4):539–542PubMedCrossRefGoogle Scholar
  68. 68.
    Ren HB, Yu T, Liu C, Li YQ (2011) Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control 22(6):837–847PubMedCrossRefGoogle Scholar
  69. 69.
    Ren X, Zhang X, Zhang X et al (2009) Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China. Public Health 123(8):540–544PubMedCrossRefGoogle Scholar
  70. 70.
    Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG et al (2000) Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 11(8):707–711PubMedCrossRefGoogle Scholar
  71. 71.
    Saltzman BS, Doherty JA, Hill DA et al (2008) Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 167(5):607–614PubMedCrossRefGoogle Scholar
  72. 72.
    Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010) Cancer risk among patients hospitalized for type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med 27(7):791–797PubMedCrossRefGoogle Scholar
  73. 73.
    Wang C, Wang X, Gong G et al (2012) Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies. Int J Cancer 130(7):1639–1648Google Scholar
  74. 74.
    Washio M, Mori M, Khan M et al (2007) Diabetes mellitus and kidney cancer risk: the results of Japan collaborative cohort study for evaluation of cancer risk (JACC study). Int J Urol 14(5):393–397PubMedCrossRefGoogle Scholar
  75. 75.
    Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71(3):360–363PubMedCrossRefGoogle Scholar
  76. 76.
    Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC (2007) Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 28(7):1561–1566PubMedCrossRefGoogle Scholar
  77. 77.
    Yang YX, Hennessy S, Lewis JD (2005) Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 3(6):587–594PubMedCrossRefGoogle Scholar
  78. 78.
    Pannala R, Basu A, Petersen GM, Chari ST (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10(1):88–95PubMedCrossRefGoogle Scholar
  79. 79.
    Polednak AP (2007) Prevalence and predictors of comorbid diabetes among newly diagnosed Hispanic cancer patients in Connecticut. Cancer Detect Prev 31(6):453–456PubMedCrossRefGoogle Scholar
  80. 80.
    Silverman DT, Schiffman M, Everhart J et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80(11):1830–1837PubMedCrossRefGoogle Scholar
  81. 81.
    Swerdlow AJ, Laing SP, Qiao Z et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92(11):2070–2075PubMedCrossRefGoogle Scholar
  82. 82.
    Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103–111PubMedCrossRefGoogle Scholar
  83. 83.
    Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47(6):1071–1078PubMedCrossRefGoogle Scholar
  84. 84.
    Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15(11):2056–2062PubMedCrossRefGoogle Scholar
  85. 85.
    Haffner SM, Shaten J, Stem MP, Smith GD, Kuller L (1996) Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple risk factor intervention trial. Am J Epidemiol 143(9):889–897PubMedCrossRefGoogle Scholar
  86. 86.
    Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88(16):1118–1126PubMedCrossRefGoogle Scholar
  87. 87.
    Oxman AD, Guyatt GH (1991) Validation of an index of the quality of review articles. J Clin Epidemiol 44(11):1271–1278PubMedCrossRefGoogle Scholar
  88. 88.
    Centers for Disease Control and Prevention National Program of Cancer Registries (2011) United States Cancer Statistics (2007) Cancer types grouped by race and ethnicity. Available at:
  89. 89.
    Cannata D, Fierz Y, Vijayakumar A, LeRoith D (2010) Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med 77(2):197–213PubMedCrossRefGoogle Scholar
  90. 90.
    Michels KB, Solomon CG, Hu FB et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the nurses’ health study. Diabetes Care 26(6):1752–1758PubMedCrossRefGoogle Scholar
  91. 91.
    Johnson JA, Bowker SL, Richardson K, Marra CA (2011) Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 54(9):2263–2271PubMedCrossRefGoogle Scholar
  92. 92.
    Baradaran N, Ahmadi H, Salem S et al (2009) The protective effect of diabetes mellitus against prostate cancer: role of sex hormones. Prostate 69(16):1744–1750PubMedCrossRefGoogle Scholar
  93. 93.
    Pierce BL, Plymate S, Ostrander EA, Stanford JL (2008) Diabetes mellitus and prostate cancer risk. Prostate 68(10):1126–1132PubMedCrossRefGoogle Scholar
  94. 94.
    Tavani A, Gallus S, Bosetti C et al (2002) Diabetes and the risk of prostate cancer. Eur J Cancer Prev 11(2):125–128PubMedCrossRefGoogle Scholar
  95. 95.
    Turner EL, Lane JA, Donovan JL et al (2011) Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study). Int J Cancer 128(2):440–446PubMedCrossRefGoogle Scholar
  96. 96.
    Dormandy JA, Charbonnel B, Eckland DJ et al (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366(9493):1279–1289PubMedCrossRefGoogle Scholar
  97. 97.
    Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560–2572PubMedCrossRefGoogle Scholar
  98. 98.
    Home PD, Pocock SJ, Beck-Nielsen H et al (2009) Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 373(9681):2125–2135PubMedCrossRefGoogle Scholar
  99. 99.
    Johnson JA, Bowker SL (2011) Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia 54(1):25–31PubMedCrossRefGoogle Scholar
  100. 100.
    Tsugawa K, Koyanagi N, Hashizume M et al (2002) Therapeutic strategy of emergency surgery for colon cancer in 71 patients over 70 years of age in Japan. Hepatogastroenterology 49(44):393–398PubMedGoogle Scholar
  101. 101.
    Koperna T, Kisser M, Schulz F (1997) Emergency surgery for colon cancer in the aged. Arch Surg 132(9):1032–1037PubMedCrossRefGoogle Scholar
  102. 102.
    Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y (2002) Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 6(1):88–94PubMedCrossRefGoogle Scholar
  103. 103.
    Davila JA, Rabeneck L, Berger DH, El-Serag HB (2005) Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci 50(9):1722–1728PubMedCrossRefGoogle Scholar
  104. 104.
    Jullumstro E, Kollind M, Lydersen S, Edna TH (2009) Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol 48(3):361–367PubMedCrossRefGoogle Scholar
  105. 105.
    Abunasra H, Lewis S, Beggs L, Duffy J, Beggs D, Morgan E (2005) Predictors of operative death after oesophagectomy for carcinoma. Br J Surg 92(8):1029–1033PubMedCrossRefGoogle Scholar
  106. 106.
    Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85(6):840–844PubMedCrossRefGoogle Scholar
  107. 107.
    Karl RC, Schreiber R, Boulware D, Baker S, Coppola D (2000) Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 231(5):635–643PubMedCrossRefGoogle Scholar
  108. 108.
    Wright CD, Kucharczuk JC, O’Brien SM, Grab JD, Allen MS (2009) Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a society of thoracic surgeons general thoracic surgery database risk adjustment model. J Thorac Cardiovasc Surg 137(3):587–596PubMedCrossRefGoogle Scholar
  109. 109.
    Zhang GH, Fujita H, Yamana H, Kakegawa T (1994) A prediction of hospital mortality after surgical treatment for esophageal cancer. Surg Today 24(2):122–127PubMedCrossRefGoogle Scholar
  110. 110.
    Chu CK, Mazo AE, Sarmiento JM et al (2010) Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma. J Am Coll Surg 210(4):463–473PubMedCrossRefGoogle Scholar
  111. 111.
    Duque JL, Ramos G, Castrodeza J et al (1997) Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica. Ann Thorac Surg 63(4):944–950PubMedCrossRefGoogle Scholar
  112. 112.
    Au J, el-Oakley R, Cameron EW (1994) Pneumonectomy for bronchogenic carcinoma in the elderly. Eur J Cardiothorac Surg 8(5):247–250PubMedCrossRefGoogle Scholar
  113. 113.
    Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC III, Deschamps C, Pairolero PC (2006) Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg 82(4):1175–1179PubMedCrossRefGoogle Scholar
  114. 114.
    Romano PS, Mark DH (1992) Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 101(5):1332–1337PubMedCrossRefGoogle Scholar
  115. 115.
    Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23):2754–2764PubMedCrossRefGoogle Scholar
  116. 116.
    Peairs KS, Barone BB, Snyder CF et al (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29(1):40–46PubMedCrossRefGoogle Scholar
  117. 117.
    Snyder CF, Stein KB, Barone BB et al (2010) Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. Prostate Cancer Prostatic Dis 13(1):58–64PubMedCrossRefGoogle Scholar
  118. 118.
    Lam EK, Batty GD, Huxley RR et al (2011) Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol 22(3):730–738PubMedCrossRefGoogle Scholar
  119. 119.
    Landman GW, Ubink-Veltmaat LJ, Kleefstra N, Kollen BJ, Bilo HJ (2008) Increased cancer mortality in type 2 diabetes (ZODIAC-3). Anticancer Res 28(2B):1373–1375Google Scholar
  120. 120.
    Noto H, Tsujimoto T, Sasazuki T et al (2011) Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 17(4):616–628PubMedCrossRefGoogle Scholar
  121. 121.
    Zhou XH, Qiao Q, Zethelius B et al (2010) Diabetes, prediabetes and cancer mortality. Diabetologia 53(9):1867–1876PubMedCrossRefGoogle Scholar
  122. 122.
    Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829–841PubMedCrossRefGoogle Scholar
  123. 123.
    (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UPDOS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131):837–853Google Scholar
  124. 124.
    (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131):854–865Google Scholar
  125. 125.
    Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360(2):129–139PubMedCrossRefGoogle Scholar
  126. 126.
    Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358(24):2545–2559PubMedCrossRefGoogle Scholar
  127. 127.
    Jiralerspong S, Palla SL, Giordano SH et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27(20):3297–3302PubMedCrossRefGoogle Scholar
  128. 128.
    Martin JH, Coory MD, Valery PC, Green AC (2009) Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer. Cancer Causes Control 20(3):355–360PubMedCrossRefGoogle Scholar
  129. 129.
    Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7):1674–1685PubMedCrossRefGoogle Scholar
  130. 130.
  131. 131.
    Beckman TJ, Cuddihy RM, Scheitel SM, Naessens JM, Killian JM, Pankratz VS (2001) Screening mammogram utilization in women with diabetes. Diabetes Care 24(12):2049–2053PubMedCrossRefGoogle Scholar
  132. 132.
    Marshall JG, Cowell JM, Campbell ES, McNaughton DB (2010) Regional variations in cancer screening rates found in women with diabetes. Nurs Res 59(1):34–41PubMedCrossRefGoogle Scholar
  133. 133.
    Zhao G, Ford ES, Ahluwalia IB, Li C, Mokdad AH (2009) Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med 24(2):270–275PubMedCrossRefGoogle Scholar
  134. 134.
    Ives DG, Lave JR, Traven ND, Schulz R, Kuller LH (1996) Mammography and pap smear use by older rural women. Public Health Rep 111(3):244–250PubMedGoogle Scholar
  135. 135.
    McBean AM, Yu X (2007) The underuse of screening services among elderly women with diabetes. Diabetes Care 30(6):1466–1472PubMedCrossRefGoogle Scholar
  136. 136.
    Karathanasi I, Kamposioras K, Cortinovis I et al (2009) Moving ahead in diabetics’ cancer screening; food for thought from the Hellenic experience. Eur J Cancer Care (Engl) 18(3):255–263CrossRefGoogle Scholar
  137. 137.
    Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Gil A (2009) Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes. Diabetes Care 32(8):1470–1472PubMedCrossRefGoogle Scholar
  138. 138.
    Lipscombe LL, Hux JE, Booth GL (2005) Reduced screening mammography among women with diabetes. Arch Intern Med 165(18):2090–2095PubMedCrossRefGoogle Scholar
  139. 139.
    Bell RA, Shelton BJ, Paskett ED (2001) Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics. Prev Med 32(2):163–167PubMedCrossRefGoogle Scholar
  140. 140.
    Owens MD, Beckles GL, Ho KK, Gorrell P, Brady J, Kaftarian JS (2008) Women with diagnosed diabetes across the life stages: underuse of recommended preventive care services. J Womens Health (Larchmt) 17(9):1415–1423CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Adedayo A. Onitilo
    • 1
    • 2
    • 3
    Email author
  • Jessica M. Engel
    • 4
  • Ingrid Glurich
    • 2
  • Rachel V. Stankowski
    • 2
  • Gail M. Williams
    • 3
  • Suhail A. Doi
    • 3
  1. 1.Department of Hematology/OncologyMarshfield Clinic Weston CenterWestonUSA
  2. 2.Marshfield Clinic Research FoundationMarshfieldUSA
  3. 3.School of Population HealthUniversity of QueenslandBrisbaneAustralia
  4. 4.Department of Hematology/OncologyMarshfield Clinic Cancer CareStevens PointUSA

Personalised recommendations